Sheppard lab

Home
Research
Research labs
Sheppard lab

AMR and bacterial evolution

Bacterial pathogens, and the rise of antimicrobial resistance, are among the greatest threats to human and animal health. The emergence and spread of these organisms is governed by basic evolutionary processes, whereby adaptive phenotypes are favoured by selection - leaving signatures in the genome.

Analysing this genome variation, we address complex questions in the ecology, epidemiology and evolution of bacteria including Campylobacter, Acinetobacter, Escherichia coli, Helicobacter, Staphylococcus and Streptococcus.

Current research can be broadly defined in three overlapping areas, described below: genome evolution, ecological genomics, and global health.

For more details, visit: https://sheppardlab.com/

Genome evolution

The genetic basis of phenotype variation. Processes such as host adaptation, zoonotic transition and emergence of virulence and antimicrobial resistance leave signatures in genomes. We develop bioinformatics approaches, such bacterial genome-wide association studies and genome covariation analyses, to explore how mutation, recombination and selection shape coadapted genomes and ecological strategies. Where possible, we validate genotype-phenotype associations through gene inactivation, functional comparison to ‘wild-type’ strains, and complementation to re-instate phenotypes.

Ecological genomics

Pathogens in the wild. Using genomics to understand the niche distribution and transmission of pathogenic bacteria requires identification of strains, and genes within strains, associated with host source, food, the environment and human disease. Analysing very large genome collections, we explain cryptic disease networks and track transmission in source-sink populations.

Global health

Interventions. In many cases the people at greatest infection risk are the least studied, specifically those in low and middle income countries. Using microbial genomics approaches I am currently working with global partners to understand One Health dynamics of pathogens to develop genomic surveillance programs, decision support modelling tools, antigen discovery for enteric livestock vaccines, and CRISPR-based targeted killing of pathogens.